What's in Borstkanker Onderzoek Groep's pipeline?

Borstkanker Onderzoek Groep has 4 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Borstkanker Onderzoek Groep's portfolio?

Top competitors by shared drug class: Fundacion Clinic per a la Recerca Biomédica.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/borstkanker-onderzoek-groep.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Borstkanker Onderzoek Groep — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Borstkanker Onderzoek Groep pipeline: 0 marketed, 0 filed, 2 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Non-Steroidal Aromatase Inhibitor	Non-Steroidal Aromatase Inhibitor	phase 3	Non-Steroidal Aromatase Inhibitor	Aromatase	Oncology
Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine	Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine	phase 3	Combination chemotherapy with anti-angiogenic monoclonal antibody	Multiple: microtubules (paclitaxel), VEGF (bevacizumab), DNA (doxorubicin), thymidylate synthase (capecitabine)	Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Fundacion Clinic per a la Recerca Biomédica · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Borstkanker Onderzoek Groep:

Cite this brief

Drug Landscape (2026). Borstkanker Onderzoek Groep — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/borstkanker-onderzoek-groep. Accessed 2026-05-17.